MetaCap

Amneal Pharmaceuticals Statistics

NASDAQ: AMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

21.12-0.27 (-1.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Amneal Pharmaceuticals by the numbers

Amneal Pharmaceuticals has a market capitalization of $7.36 billion based on 348.41M shares outstanding. Its trailing P/E ratio is 52.8, above the 3-company peer median of 47.8, and its forward P/E is 17.1. The stock trades 4.9% above its 50-day average and 29.8% above its 200-day average.

Average daily trading volume is 3.16M shares, or about $66.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AMRX valuation vs. peer median

AMRX compared with the median of 8 peer companies
MetricAMRXPeer medianDifference
Market cap$7.36B$7.46B-1%
P/E (TTM)52.847.8+10%
Forward P/E17.135.5-52%
Avg. volume3.16M1.18M+168%

Peer median across 8 companies: KNSA, ALKS, RYTM, CYTK, PTGX, CORT, SMMT, AXSM.

Valuation

Price / sales (latest FY)
2.44

Price and trading

Previous close
21.39
Open
21.25
Day range
21.07 – 21.70
52-week range
11.71 – 22.13
52-week change
+76.74%
Beta
—
Volume
1.67M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
7.36B
Pe
52.80
Forward Pe
17.13
Eps
0.40
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
22.13
Week52 Low
11.71
Avg Volume
3.16M
Shares Outstanding
348.41M
Ma50
20.13
Ma200
16.28
Earnings Date
Nov 3, 2026
Pct From52w High
-4.54%
Pct From52w Low
80.36%

Related